This inventor holds 4 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Ascendis Pharma Growth Disorders A/s, Genmab A+s. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2026
Title: Inventor Vibeke Miller Breinholt: Innovating in Human Antibody Research
Introduction
Vibeke Miller Breinholt, an accomplished inventor based in Frederiksberg, Denmark, has made significant contributions to the field of biomedicine through her innovative work on human antibodies. Her patents focus on advancements in therapeutic and diagnostic methods that harness the potential of monoclonal antibodies, showcasing her expertise and commitment to scientific progress.
Latest Patents
Breinholt holds two notable patents, both centered around human antibodies against tissue factor. The first patent, titled "Human antibodies against tissue factor and methods of use thereof," discloses isolated human monoclonal antibodies that bind specifically to human tissue factor (TF). This invention also includes antibody-based compositions and molecules, providing a foundation for pharmaceutical applications. Additionally, therapeutic and diagnostic methods utilizing these antibodies are detailed, pointing towards a wide range of potential medical applications.
The second patent reinforces the innovations outlined in the first. It again presents isolated human monoclonal antibodies binding to human TF, along with related antibody-based compositions. The patent emphasizes the pharmaceutical compositions that comprise these antibodies, further outlining their applications in therapeutic and diagnostic methodologies.
Career Highlights
Vibeke Miller Breinholt is a key member of Genmab A/S, a leading biotechnology company focused on the development of innovative antibody therapeutics. Through her time at Genmab, she has collaborated on groundbreaking research and contributed to multiple projects aimed at harnessing the immune system to fight diseases, particularly cancer.
Collaborations
In her professional journey, Breinholt has worked alongside esteemed colleagues, including Sandra Verploegen and David P E Satijn. Their shared expertise and collaborative efforts have contributed to the advancement of antibody-based therapies, demonstrating the power of teamwork in scientific innovation.
Conclusion
Vibeke Miller Breinholt exemplifies the spirit of innovation in the biotechnology field through her groundbreaking patents and work at Genmab A/S. Her dedication to researching human antibodies and the development of effective therapeutic methods holds great promise for the future of medicine. As her career progresses, the impacts of her innovations will likely continue to shape the landscape of biomedical research and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile